申请人:——
公开号:US20040132807A1
公开(公告)日:2004-07-08
The present invention relates to know and novel substituted aurones active as telomerase inhibitors, to their use as therapeutic agents, in particular as antitumoral agents, to a process for their preparation as to pharmaceutical compositions comprising them.
本发明涉及一种新颖的取代的黄酮类化合物,作为端粒酶抑制剂的活性,以及它们作为治疗剂,特别是抗肿瘤剂的用途,以及它们的制备过程和包含它们的制药组合物。